Literature DB >> 25268656

Effect of rehabilitation and botulinum toxin injection on gait in chronic stroke patients: a randomized controlled study.

Nicolas Roche1, Raphaël Zory, Antoine Sauthier, Celine Bonnyaud, Didier Pradon, Djamel Bensmail.   

Abstract

BACKGROUND: Botulinum toxin injections are used to treat spasticity in stroke. Although this treatment is effective on muscle tone, its effect on functional gait-related activities remains uncertain.
OBJECTIVE: The aim of this randomized controlled trial was to determine the effect of a self-rehabilitation programme as an adjunct to botulinum toxin injections on gait-related activities in patients with chronic hemiparesis.
METHODS: Thirty-five outpatients were included. Each patient was randomized to 1 of 2 groups: botulinum toxin + standardized self-rehabilitation programme (R group, n = 19) or botulinum toxin alone (C group, n = 16). Each patient was evaluated with the following tests before botulinum toxin injections and one month afterwards: 10-m timed walk, Timed Up and Go, distance covered in 6 min over an ecological circuit, and the stair test.
RESULTS: There were significant improvements in the R group compared with the C group: maximal gait speed improved by 8% (p = 0.003); distance covered in 6 min over an ecological circuit increased by 7.1% (p = 0.01); and time to ascend and to descend a flight of stairs decreased by 9.8% (p = 0.003) and 6.6% (p = 0.009), respectively. The self-rehabilitation programme was well tolerated and safe.
CONCLUSION: These results strongly suggest that a standardized self-rehabilitation programme constitutes a useful adjunct to botulinum toxin injections in order to improve gait-related activities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25268656     DOI: 10.2340/16501977-1887

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  9 in total

1.  Factors Influencing Gait Velocity Improvement Following Botulinum Toxin Injection for Spasticity of the Plantar Flexors in Patients with Stroke.

Authors:  Kazuki Fujita; Yasutaka Kobayashi; Masahito Hitosugi; Tomomi Nomura; Tomoko Nishida; Yuichi Tsushima; Tomoki Ogawa; Hirotaka Kinoshita; Hideaki Hori
Journal:  Prog Rehabil Med       Date:  2020-10-07

2.  Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial.

Authors:  Nicoletta Cinone; Sara Letizia; Luigi Santoro; Salvatore Facciorusso; Raffaella Armiento; Alessandro Picelli; Maurizio Ranieri; Andrea Santamato
Journal:  Toxins (Basel)       Date:  2019-04-08       Impact factor: 4.546

Review 3.  Botulinum Toxin Therapy Combined with Rehabilitation for Stroke: A Systematic Review of Effect on Motor Function.

Authors:  Takatoshi Hara; Ryo Momosaki; Masachika Niimi; Naoki Yamada; Hiroyoshi Hara; Masahiro Abo
Journal:  Toxins (Basel)       Date:  2019-12-05       Impact factor: 4.546

4.  Effects of a 6-month self-rehabilitation programme in addition to botulinum toxin injections and conventional physiotherapy on limitations of patients with spastic hemiparesis following stroke (ADJU-TOX): protocol study for a randomised controlled, investigator blinded study.

Authors:  Celine Bonnyaud; Philippe Gallien; Pierre Decavel; Philippe Marque; Claire Aymard; Frédéric Pellas; Marie-Eve Isner; François Constant Boyer; François Muller; Jean-Christophe Daviet; Patrick Dehail; Brigitte Perrouin-Verbe; Nicolas Bayle; Emmanuel Coudeyre; Dominic Perennou; Isabelle Laffont; Jacques Ropers; Nabila-Yasmine Domingo-Saidji; Djamel Bensmail; Nicolas Roche
Journal:  BMJ Open       Date:  2018-08-30       Impact factor: 2.692

5.  Rectus femoris hyperreflexia contributes to Stiff-Knee gait after stroke.

Authors:  Tunc Akbas; Kyoungsoon Kim; Kathleen Doyle; Kathleen Manella; Robert Lee; Patrick Spicer; Maria Knikou; James Sulzer
Journal:  J Neuroeng Rehabil       Date:  2020-08-26       Impact factor: 4.262

6.  A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: An international group consensus.

Authors:  Gerard E Francisco; Alexander Balbert; Ganesh Bavikatte; Djamel Bensmail; Stefano Carda; Thierry Deltombe; Nathalie Draulans; Steven Escaldi; Raphael Gross; Jorge Jacinto; Nicholas Ketchum; Franco Molteni; Susana Moraleda; Michael W ODell; Rajiv Reebye; Patrik Säterö; Monica Verduzco-Gutierrez; Heather Walker; Jörg Wissel
Journal:  J Rehabil Med       Date:  2021-01-01       Impact factor: 2.912

7.  Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A: Clinical Implications from Ultrasonographic Evaluation.

Authors:  Marco Battaglia; Lucia Cosenza; Lorenza Scotti; Michele Bertoni; Marco Polverelli; Alberto Loro; Andrea Santamato; Alessio Baricich
Journal:  Toxins (Basel)       Date:  2021-12-12       Impact factor: 4.546

8.  European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.

Authors:  Bo Biering-Soerensen; Valerie Stevenson; Djamel Bensmail; Klemen Grabljevec; Mercedes Martínez Moreno; Elke Pucks-Faes; Joerg Wissel; Mauro Zampolini
Journal:  J Rehabil Med       Date:  2022-01-03       Impact factor: 2.912

9.  Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop.

Authors:  Harald Hefter; Werner Nickels; Dietmar Rosenthal; Sara Samadzadeh; Philipp Albrecht
Journal:  Toxins (Basel)       Date:  2021-07-02       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.